0001225208-20-011914.txt : 20200930 0001225208-20-011914.hdr.sgml : 20200930 20200930211038 ACCESSION NUMBER: 0001225208-20-011914 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20200930 DATE AS OF CHANGE: 20200930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39562 FILM NUMBER: 201214049 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmonx Corp CENTRAL INDEX KEY: 0001127537 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 700 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-364-0400 MAIL ADDRESS: STREET 1: 700 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: PULMONX DATE OF NAME CHANGE: 20001031 3 1 doc3.xml X0206 3 2020-09-30 0 0001127537 Pulmonx Corp LUNG 0000885725 BOSTON SCIENTIFIC CORP 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 Common Stock 141.0000 D Series A-1 Preferred Stock Common Stock 40705.0000 D Series B-1 Preferred Stock Common Stock 47536.0000 D Series C-1 Preferred Stock Common Stock 23180.0000 D Series D-1 Preferred Stock Common Stock 542.0000 D Series E-1 Preferred Stock Common Stock 6215.0000 D Series F-1 Preferred Stock Common Stock 3787878.0000 D Series G-1 Preferred Stock Common Stock 2081909.0000 D Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. /s/ Vance R. Brown Vice President and Chief Corporate Counsel 2020-09-30